drugset / Trial / NCT01993667
Acetazolamide for the Prevention of High Altitude Illness: a Comparison of Dosing
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a phase 4, randomized, double-blinded interventional trial comparing alternative doses of Acetazolamide for the prevention of High Altitude Illness.
Timeline
- Start
- 2012-03
- Primary completion
- 2016-11
- Completion
- 2016-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Acetazolamide | Small molecule | 62.5 mg | Oral |
| Subject | Acetazolamide | Small molecule | 125 mg | Oral |